The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome

European Journal of Preventive Cardiology

Volumn 20, Issue 6, 2013, Pages 1061-1068

  Haring, Robin ^a   Völzke, Henry ^a   Spielhagen, Christin ^a   Nauck, Matthias ^a   Wallaschofski, Henri ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

men; metabolic syndrome; sex hormone binding globulin; Total testosterone

Indexed keywords

ANTIHYPERTENSIVE AGENT; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CROSS-SECTIONAL STUDY; ELEVATED BLOOD PRESSURE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN FUNCTION;

MEN; METABOLIC SYNDROME; SEX HORMONE-BINDING GLOBULIN; TOTAL TESTOSTERONE;

ADULT; AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; GERMANY; HUMANS; INCIDENCE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TIME FACTORS; YOUNG ADULT;

EID: 84887086279     PISSN: 20474873     EISSN: None     Source Type: Journal    
DOI: 10.1177/2047487312452965     Document Type: Article

References (34)

1. Caldwell JD, Suleman F, Chou SH, Shapiro RA, Herbert Z, Jirikowski GF. Emerging roles of steroid-binding globulins. Hormon Stoffwechselforsch. 2006 ; 38: 206-218
2. Ding EL, Song Y, Manson JE, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009 ; 361: 1152-1163
3. Tchernof A, Despres JP. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Hormon Stoffwechselforsch. 2000 ; 32: 526-536
4. Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. Int J Epidemiol. 2011 ; 40: 189-207
5. Haring R, Volzke H, Felix SB, et al. Prediction of metabolic syndrome by low serum testosterone levels in men: results from the study of health in Pomerania. Diabetes. 2009 ; 58: 2027-2031
6. Rodriguez A, Muller DC, Metter EJ, et al. Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J Clin Endocrinol Metab. 2007 ; 92: 3568-3572
7. Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006 ; 91: 843-850
8. Bhasin S, Jasjua GK, Pencina M, et al. Sex hormone-binding globulin, but not testosterone, is associated prospectively and independently with incident metabolic syndrome in men: the Framingham heart study. Diabetes Care. 2011 ; 34: 2464-2470
9. Völzke H, Alte D, Schmidt CO, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011 ; 40: 294-307
10. Haring R, Alte D, Volzke H, et al. Extended recruitment efforts minimize attrition but not necessarily bias. J Clin Epidemiol. 2009 ; 62: 252-260
11. Haring R, Wallaschofski H, Nauck M, Dorr M, Baumeister SE, Volzke H. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology (Baltimore, MD). 2009 ; 50: 1403-1411
12. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertension. 2007 ; 25: 1105-1187
13. Friedrich N, Volzke H, Rosskopf D, et al. Reference ranges for serum dehydroepiandrosterone sulfate and testosterone in adult men. J Androl. 2008 ; 29: 610-617
14. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999 ; 84: 3666-3672
15. Nauck M, Winkler K, Marz W, Wieland H. Quantitative determination of high-, low-, and very-low-density lipoproteins and lipoprotein(a) by agarose gel electrophoresis and enzymatic cholesterol staining. Clin Chem. 1995 ; 41: 1761-1767
16. Haring R, Baumeister SE, Völzke H, et al. Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia. Eur J Cardiovasc Prev Rehabil. 2011 ; 18: 86-96
17. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 ; 120: 1640-1645
18. Hannemann A, Meisinger C, Bidlingmaier M, et al. Association of plasma aldosterone with the metabolic syndrome in two German populations. Eur J Endocrinol. 2011 ; 164: 751-758
19. Schipf S, Alte D, Voelzke H, et al. Prävalenz des Metabolischen Syndroms in Deutschland: Ergebnisse der Study of Health in Pomerania (SHIP). Diabetol Stoffwechsel. 2010 ; 5: 161-168
20. Haring R, Wallaschofski H, Nauck M, et al. Total and cardiovascular disease mortality predicted by metabolic syndrome is inferior relative to its components. Exp Clin Endocrinol Diabetes. 2010 ; 118: 685-691
21. Lidfeldt J, Nyberg P, Nerbrand C, Samsioe G, Schersten B, Agardh CD. Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study. Diabetes Obes Metab. 2003 ; 5: 106-112
22. Afifi AA, Kotlerman JB, Ettner SL, Cowan M. Methods for improving regression analysis for skewed continuous or counted responses. Annu Rev Public Health. 2007 ; 28: 95-111
23. Ohlsson C, Wallaschofski H, Lunetta KL, et al. Genetic determinants of serum testosterone concentrations in men. PLoS Genetics. 2011 ; 7: e1002313 - e1002313
24. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011 ; 96: 3007-3019
25. Haring R, Baumeister SE, Volzke H, et al. Prospective association of low serum total testosterone levels with health care utilization and costs in a population-based cohort of men. Int J Androl. 2010 ; 33: 800-809
26. Caldwell JD, Jirikowski GF. Sex hormone binding globulin and aging. Hormon Stoffwechselforsch. 2009 ; 41: 173-182
27. Haring R, Ittermann T, Volzke H, et al. Prevalence, incidence and risk factors of testosterone deficiency in a population-based cohort of men: results from the study of health in Pomerania. Aging Male. 2010 ; 13: 247-257
28. Laaksonen DE, Niskanen L, Punnonen K, et al. The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab. 2005 ; 90: 712-719
29. Barrett-Connor E, Khaw KT, Yen SS. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol. 1990 ; 132: 895-901
30. Spark RF. Testosterone, diabetes mellitus, and the metabolic syndrome. Curr Urol Rep. 2007 ; 8: 467-471
31. Laaksonen DE, Niskanen L, Punnonen K, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004 ; 27: 1036-1041
32. Schipf S, Haring R, Friedrich N, et al. Low total testosterone is associated with increased risk of incident type 2 diabetes mellitus in men: results from the Study of Health in Pomerania (SHIP). Aging Male. 2011 ; 14: 168-175
33. Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005 ; 95 (Suppl. 1). S144 - S150
34. Cook NL, Romashkan S. Why do we need a trial on the effects of testosterone therapy in older men?. Clin Pharmacol Therapeut. 2011 ; 89: 29-31